Enterprise Value
380.7M
Cash
369.9M
Avg Qtr Burn
-18.57M
Short % of Float
12.76%
Insider Ownership
0.49%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
STAR-0215 Details Hereditary angioedema | Phase 2 Data readout | |
STAR-0215 Details Hereditary angioedema | Phase 1/2 Data readout | |
STAR-0310 Details Atopic dermatitis | Phase 1a Initiation |